SSSedigheh Shams

Sedigheh Shams

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Sedigheh Shams has a total of 45 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Intracellular Cobalamin Defect in Early Infancy: A Cause of Hypotonia and Cytopenias

    by Maryam Saeedi, Razieh Sangsari, Parastoo Rostami, Kayvan Mirnia, Sedigheh Shams, Sepideh Rahmati

    Intracellular cobalamin metabolism defects (ICMDs) are rare but inherited disorders that disrupt the conversion of cobalamin into its active cofactors, methylcobalamin and adenosylcobalamin. We report a 40‐day‐old female infant with progressive hypotonia, poor feeding, hydrocephalus, and pancytopenia, whose metabolic profile demonstrated severe hyperhomocysteinemia, elevated urinary methylmalonic acid, and low methionine despite normal serum vitamin B12. Bone marrow evaluation revealed profound hypercellularity with megaloblastic changes and hypersegmented neutrophils. These findings suggested an intracellular cobalamin defect, most consistent with the cblC subtype. Molecular analysis confirmed a homozygous frameshift mutation in the MMACHC gene, establishing the diagnosis of methylmalonic aciduria and homocystinuria, cblC type. Treatment with hydroxocobalamin, betaine, and folinic acid led to stabilization of hematologic parameters and significant clinical and biochemical improvement; however, it is important to recognize that therapy is not curative, and long‐term neurodevelopmental outcomes may remain guarded, especially in early‐onset cases.

  • Open Access

    Alteration of Plasma Amino Acid Concentrations in Iranian Children with COVID-19

    by Sedigheh Shams, Aileen Azari-Yam, Moeinadin Safavi, Zahra Zamani, Maryam Sotoudeh-Anvari, Meisam Sharifzadeh Ekbatani, Mohammad-Taghi Haghi-Ashtiani, Fatemeh Mozafari, Bahareh Yaghmaie, Leila Shafeghat

    COVID-19 is an acute viral disease that has so far infected more than 200 million and killed more than four million worldwide. It affects the immune system and other organs. Here, we investigated the level of free plasma amino acids in COVID-19 patients and compared them with non-COVID-19 subjects. We also compared amino acids levels in critically ill patients admitted to the intensive care unit (ICU) with non-ICU patients and expired and recovered patients. Twenty-six COVID-19 patients and 32 non-COVID-19 subjects were included in the study. The mean of glutamic acid, serine, glycine, threonine, phenylalanine, leucine, lysine, alanine, arginine, aspartic acid, and ornithine was significantly higher in cases than controls. In addition, the mean of glutamine was significantly lower in patients than controls ( vs. , ). Low level of glutamine and isoleucine was seen in the majority of ICU and expired patients, respectively. Logistic regression analysis showed low level of isoleucine as a predictor variable in mortality ( , , and ). There was a positive and significant relationship between some amino acids levels, serum liver enzymes, and sodium concentrations. There was also a significant but negative correlation between histidine levels, ESR, and ferritin. Phenylalanine had a highly positive relationship with serum procalcitonin in patients ( , ). Our studies have shown the alteration of plasma amino acids concentration in COVID-19 patients. These changes are more evident in critically ill and at-risk patients.


  • Open Access

    Evaluation of Patients Referred to Children's Medical Center Laboratory for Diagnosis of Mucopolysaccharidoses: Eight Years' Experience from Iran

    by Rokhsareh Jafaryazdi, Sedigheh Shams, Aria Setoodeh, Reza Shervin Badv, Vahid Ziaee, Farzaneh Abbasi, Mohammad Taghi Haghi Ashtiani, Fatemeh Mozafari, Lila Shafeghat

    Mucopolysaccharidoses (MPSs) are rare lysosomal storage diseases, resulting from deficiencies of enzymes responsible for Glycosaminoglycans (GAGs) degradation. This leads to accumulation of GAGs in tissues and their excretion in urine, with a wide variety of manifestations. Early diagnosis of MPSs is strictly recommended due to available therapy that can slow down disease progression during the early ages. This study aimed to evaluate patients with suspected MPS referred to Children's Medical Center laboratory over eight years. We also evaluated the usefulness of urine GAG as a screening test for identification of such patients. A total of 1414 patients (40% female, 60% male, with mean age 3.1 ± 4.1years) have participated in this study. The urinary GAG analysis (uGAG) was performed by 1, 9-dimethyl-methylene blue (DMMB) and Berry spot test (BST). All patients with positive and mild positive results or with disease-related symptoms were evaluated in terms of definitive diagnosis, received treatments, morbidity, and mortality rate. In 407 (36.5%) patients uGAG were positive or mild positive, of which 26.3% suffered from one of the types of MPSs, 28.5% suffered from other diseases, 32.9% were undiagnosed, 12.3% were apparently healthy, and 19 died. The negative predictive value of uGAG test in our study was 100%. About 21% of MPSs patients received enzyme replacement therapy, while four patients underwent stem cell transplants. The rest received supportive care. We concluded that a combination of DMMB and BST methods has acceptable sensitivity for screening suspicious MPS patients.

    • 1 June 2018
      • Vol. 12  (3) , 24-31
    Open Access

    Serum Total Antioxidant Capacity of Epileptic Children before and after Monotherapy with Sodium Valproate, Carbamazepine, and Phenobarbital

    by Mahmoud Reza Ashrafi, Reza Azizi Malamiri, Sedigheh Shams, Neda Rashidi Ranjbar, Sara Ebrahimi Nasrabadi, Mohammadtaghi Haghi Ashtiani, Nargess Saladjegheh, Varasteh Vakili Zarch

    Objectives This case-control study was carried out to compare serum total antioxidant capacity (TAC) in the newly diagnosed children with epilepsy and that of a control group of healthy children at the same age and probable effects of antiseizure medications prescription on it. Materials & Methods Overall, 130 participants (65 in each group) aged between 1 and 17 yr old were enrolled. The study was conducted in Children's Medical Center, the Pediatrics Center of Excellence, Tehran, Iran in 2015. Serum TAC test was done for both control and patients group before antiseizure medications therapy and after 3 months of monotherapy with sodium valproate, carbamazepine and phenobarbital in patients. Serum TAC values were measured based on Erel's method using an automated commercial kit. This method is based on the bleaching of the characteristic color of a more stable 2, 2'-azinobis(3-ethylbenzothiazoline-6-sulfonic acid) radical cation by antioxidants. The results were expressed in mmol Trolox equivalent/1. Results Serum TAC values were significantly lower in the patients group before drug administration [mean (SD): 1.31 (0.19) mmol/L] in comparison with the control group [mean (SD): 1.46 (0.21) mmol/L] (P<0.00 I). In the patient's group, no differences were found in the serum TAC before and 3 months after anti seizure medications monotherapy. Conclusion Reduced serum TAC and an increased vulnerability to oxidative stress should be considered as an etiologic factor in the children with epilepsy.


  • Open Access

    Reference Interval for Plasma Free Amino Acids in Iranian Children Using Reverse Phase High Performance Liquid Chromatography

    by Maryam Monajemzadeh, Sedigheh Shams, Shahrzad Mahdavi Izadi, Seerat Elahi, Mohammad Taghi Haghi Ashtiani, Bahar Ashjaei

    Background: Brain damage and mental retardation in children can be caused by either excess or depletion of certain amino acids. Up to now there is no reliable reference interval for free plasma amino acid in Iranian children. Objectives: The aim of this study was to provide the reference intervals of free plasma amino acid in healthy Iranian children using high performance liquid chromatography (HPLC) as an accurate method. Methods: 133 children referred to Children’s Medical Center, Tehran, Iran for the annual checkup entered the study after filling out the informed consent form. Demographic data and blood samples after overnight fasting were collected. Plasma amino acid concentrations were determined by reverse phase HPLC (RP-HPLC) equipped with a fluorescence detector after precolumn derivatization of amino acids with o-phthalaldehyde (OPA). Results: Female children exhibited significantly higher plasma concentrations of taurine and lysine than male children. Other 20 amino acid values were not significantly different between two gender groups. Positive correlation was obsereved between age and taurine, leucine and lysine. Conclusions: Our data provided reference intervals of free plasma amino acids in healthy Iranian children. We believe our data can be used as a guideline for pediatricians to identify the significantly deviated amino acid values in children with medical issues such as genetic disorders and some acquired illnesses. Our data is also applicable for further investigations in the field of family medicine. Keywords: Amino Acid; High Performance Liquid Chromatography; Reference Intervals; Children

    • 1 June 2011
      • Vol. 21  (2) , 159-165
    Open Access

    Total Antioxidant Status in Patients with Major β-Thalassemia

    by Fatemeh Bazvand, Sedigheh Shams, Mahtab Borji Esfahani, Lili Koochakzadeh, Maryam Monajemzadeh, Mohammad-Taghi Haghi Ashtiani, Nima Rezaei

    Objective: Beta-thalassemia major is an autosomal recessive disease causing severe and hemolytic anemia, which begins about 2-6 months after birth. Iron overload, which arises from recurrent transfusion and ineffective erythropoiesis, can enhance oxidative stress in thalassemic patients. The aim of this study was to evaluate the serum total antioxidant capacity of patients with beta-Thalassemia major. Methods: Sixty six Iranian patients with beta-thalassemia major and 66 age-gender matched controls were evaluated for serum total antioxidant status (TAS), uric acid (UA), bilirubin and albumin. In I addition, serum ferritin and transaminases were recorded in these subjects. Findings: Significant increases of TAS, UA, and bilirubin were observed in the patient group, compared with the control group (P<0.01). Mean TAS and bilirubin in male patients was higher than in females (P=0.005 and P=0.008, respectively). There was also direct correlation between TAS and albumin (P<0.001), bilirubin (P<0.001) and UA (P=0.002). Conclusion: Endogenous antioxidants such as ferritin, UA and bilirubin can result in increased level of TAS in the patients with Beta-thalassemia major. Compensatory excess of TAS to oxidative stress could also be the reason for difference between our findings and previous studies.


    • 1 February 2010
      • Vol. 51  (2) , 116-9

    The prevalence of iron deficiency anaemia in female medical students in Tehran.

    by S Shams, H Asheri, A Kianmehr, Vahid Ziaee, L Koochakzadeh, M Monajemzadeh, M Nouri, H Irani, N Gholami

    Female adolescents and adults are among the population groups who are most affected by iron deficiency. Thus, the aim of this study was to investigate the prevalence of iron deficiency and iron deficiency anaemia in female students aged 18 to 25 years old from the Tehran University of Medical Sciences, Iran. 295 female university students participated in the study. The mean corpuscular volume (MCV) and haemoglobin (Hb), serum ferritin, serum iron and total iron binding capacity (TIBC) levels were measured. Iron deficiency anaemia was defined as a situation where Hb is less than 12 g/dL, MCV is less than 78 microm3, ferritin is less than 12 ng/ml or transferin saturation (TS) (iron/TIBC x 100) is less than 15 percent, Iron deficiency (ID) was defined as a situation where Hb is greater than or equal to 12 g/dL, MCV is greater than or equal to 74 microm3, ferritin is less than 12 ng/ml or TS is less than 15 percent. The complete data was available for 237 students. The prevalence of ID was 40.9 percent and that of IDA was 3.8 percent. Normal iron status was found in 49.8 percent of the subjects. The remaining (5.5 percent) had other kinds of anaemia or required confirmatory tests. ID is common among 18 to 25-year-old Iranian female university students. Iron supplementation is thus required for the target group.